HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $56

Benzinga · 4d ago
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $56.